http://www.house.gov/smbiz/hearings/...13-08-rick.pdf


Excerpt
It is a sad reality that there is a lot we still do not understand about neurological diseases. There are many investigations into compounds that show therapeutic promise in pre-clinical and even early clinical
stages in which the research is dropped and no actual therapies are developed. That is why our community is heavily invested in any potential therapy that is beginning to show real promise. We have one now, Spheramine, that is in Phase II clinical trials. Spheramine, quite simply, injects retinal cells into the brain, surgically, to provide a continuous source of dopamine. While this trial is now in Phase II and our community is
quite enthusiastic about its promise, the animal research and Phase I research was funded through an SBIR grant.

frank_ger